Can a 16-Session program tame ADHD homework chaos? new study aims to find out

NCT ID NCT04465708

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a 16-session program called HOPS can help 6th to 8th graders with ADHD improve their organization, time management, and planning skills. Researchers are working with 240 students and their teachers in real school settings to see if the program works outside of a research lab. The goal is to give schools a simple, effective tool to support students who struggle with homework and staying organized.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Homework, Organization, and Planning Skills (HOPS) program
What this could lead to
If successful, this could provide schools with a proven, low-cost program to help students with ADHD improve their academic skills and reduce daily struggles.
What could go wrong
This is a replication study, not a new treatment. The program may not work as well in real-world school settings as it did in the original research. Results depend on how well school staff deliver the program.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 240 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2021

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

11 to 15 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: STUDENTS 1. Male or female students in grades 6 through 8. 2. Student is in a general education classroom. 3. Student is nominated for the study by at least one teacher(s) who rates the student as needing the intervention and having OTMP skills deficits that have a negative impact on academic performance (rating \> 3 on a 4-point scale on at least one of four interference items of COSS-T) 4. Parental/guardian permission (informed consent) and student assent. PARENTS 1\. The parent/legal guardian's child is eligible for the study SCHOOL PROVIDERS 1\. School providers will be chosen by school administrators as personnel who are capable of delivering the HOPS intervention (HOPS-ST) in the school context. RESEARCH PROVIDER 1. A person with experience providing instruction or intervention to students in a school context. 2. A member of the research team who will provide the HOPS intervention to the HOPS-RT condition 3. Has consented to be a "secondary research participant" Exclusion Criteria: STUDENTS 1. Students will be excluded if they are in a pull-out special education classroom for more than 50% of the day, because the organizational demands for these students may differ from those placed mostly in general education. 2. Students with a one-to-one aide will be excluded because the presence of an aide substantially alters how an organizational intervention is implemented. 3. Students from families in which both caregivers do not speak English will be excluded because the program has not yet been developed for non-English speakers. 4. Students who may have participated in HOPS before (as it is a commercially-available program) is not eligible to participate in this study. PARENTS 1. Parents who are not fluent in English are excluded since at this time because the intervention and many of the study outcome measures are not available in other languages. SCHOOL PROVIDERS 1\. Any school professional who declines to participate will not be enrolled. RESEARCH PROVIDERS 1\. Does not consent to be a "secondary research participant"

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyperactivity disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19146, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.